Preparing for the age of therapeutic trials in frontotemporal lobar degeneration.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 34408005.
- Also identified by DOI 10.1136/jnnp-2021-327497 and PMC identifier 8967129.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
There is a rapidly growing field of therapeutic development for familial forms of FTLD and Peakman et al address the important need for adequate clinical tools to measure treatment effect in this issue of JNNP.
Medical subject headings
- Clinical Trials as Topic
- Frontotemporal Lobar Degeneration